Literature DB >> 5009465

Quantitative determination of the bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids.

J Rieder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5009465     DOI: 10.1159/000220833

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


× No keyword cloud information.
  35 in total

1.  Maternal and transplacental kinetics of trimethoprim and sulfamethoxazole, separately and in combination.

Authors:  D W Reid; G Caille; N R Kaufmann
Journal:  Can Med Assoc J       Date:  1975-06-14       Impact factor: 8.262

2.  [An investigation into the levels of a trimethoprim-sulphamethoxazole combination in the ventricular fluid of neurosurgical patients (author's transl)].

Authors:  H Friedrich; G Hänsel
Journal:  Acta Neurochir (Wien)       Date:  1977       Impact factor: 2.216

3.  Pharmacokinetics of sulphamethoxazole in man: effects of urinary pH and urine flow on metabolism and renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole.

Authors:  T B Vree; Y A Hekster; A M Baars; J E Damsma; E van der Kleijn
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

4.  The comparison of some pharmacokinetic parameters of sulphadimethoxine estimated by high performance liquid chromatography and three spectrophotometric methods.

Authors:  A Klimowicz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jul-Sep       Impact factor: 2.441

5.  Pharmacokinetics of N1-acetyl- and N4-acetylsulphamethoxazole in man.

Authors:  T B Vree; Y A Hekster; J E Damsma; E van der Kleijn; W J O'Reilly
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

6.  Pharmacokinetics of sulfadiazine and trimethoprim in man.

Authors:  F Andreasen; L Elsborg; S Husted; O Thomsen
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

Review 7.  Clinical pharmacokinetics of co-trimazine.

Authors:  T Bergan; B Ortengren; D Westerlund
Journal:  Clin Pharmacokinet       Date:  1986 Sep-Oct       Impact factor: 6.447

8.  Antibacterial activity of co-trimazine in vitro and in vivo.

Authors:  B Ekström; H Fellner; U Forsgren; L Magni; B Ortengren
Journal:  Infection       Date:  1979       Impact factor: 3.553

9.  Age-related alterations in trimethoprim-sulfadiazine disposition following oral or parenteral administration in calves.

Authors:  C L Guard; W S Schwark; D S Friedman; P Blackshear; M Haluska
Journal:  Can J Vet Res       Date:  1986-07       Impact factor: 1.310

10.  Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Authors:  R B Patel; P G Welling
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.